Live Breaking News & Updates on Venatorx Pharmaceuticals Inc

Stay updated with breaking news from Venatorx pharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA issues CRL for Venatorx's antibiotic combo in UTIs

The good news is that the U.S. FDA’s complete response letter (CRL) for Venatorx Pharmaceuticals Inc.’s intravenous antibiotic combination, cefepime-taniborbactam, in complicated urinary tract infections (cUTIs) requested no additional clinical testing. The bad news is the inevitable delay for a drug Venatorx and partner Melinta Therapeutics Inc. are aiming to position as a much-needed option for the fight against drug-resistant gram-negative infections. ....

Melinta Therapeutics Inc , Venatorx Pharmaceuticals Inc , Venatorx Pharmaceuticals , Melinta Therapeutics , Complicated Urinary Tract Infections , Cefepime Taniborbactam , Complete Response Letter , Venatorx Pharmaceuticals Inc , Melinta Therapeutics Inc , Beta Lactamase Inhibitor , Beta Lactam , Acute Pyelonephritis , Gram Negative Bacteria ,